Literature DB >> 16914092

Influence of GBV-C infection on the endogenous activation of the IFN system in HIV-1 co-infected patients.

M R Capobianchi1, E Lalle, F Martini, F Poccia, G D'Offizi, G Antonucci, I Abbate, F Dianzani.   

Abstract

BACKGROUND: GB virus C (GBV-C) co-infection is associated with a better prognosis in HIV-infected persons. Since interferon activation can be one of the possible mechanisms involved in GBV-C-driven protection against HIV, we compared the endogenous activation of the interferon system in PBMC from GBV-C-positive and -negative patients infected with HIV-1.
METHODS: The expression of interferon related genes was analyzed in 20 GBV-C positive and 20 GBV-C-negative HIV-infected patients, comparable in terms of CD4 cell counts and HIV viral loads. The levels of mRNA for interferon-related genes (2-5-OAS, MxA, interferon AR-1 and PKR) in PBMC were measured by real time RT-PCR, using B-actin as internal control.
RESULTS: The endogenous levels of all the Interferon-related genes in HIV/GBV-C co-infected patients were higher than in HIV mono-infected subjects. The difference was statistically significant for PKR mRNA. Direct positive correlation was found between PKR and all the other interferon-related genes, suggesting a coordinated activation of the interferon system.
CONCLUSIONS: Enhanced activation of the interferon system occurs in GBV-C-positive, as compared to GBV-C-negative patients harbouring HIV-1. These data may be relevant to understand the GBV-C-driven protection against HIV, suggesting that the endogenous activation of the interferon system can contribute to the control of HIV replication.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16914092

Source DB:  PubMed          Journal:  Cell Mol Biol (Noisy-le-grand)        ISSN: 0145-5680            Impact factor:   1.770


  7 in total

Review 1.  Role of GB virus C in modulating HIV disease.

Authors:  Carolynne Schwarze-Zander; Jason T Blackard; Juergen K Rockstroh
Journal:  Expert Rev Anti Infect Ther       Date:  2012-05       Impact factor: 5.091

2.  Cytokine/chemokine expression associated with Human Pegivirus (HPgV) infection in women with HIV.

Authors:  Jason T Blackard; Gang Ma; Jeffrey A Welge; Lynn E Taylor; Kenneth H Mayer; Robert S Klein; David D Celentano; Jack D Sobel; Denise J Jamieson; Caroline C King
Journal:  J Med Virol       Date:  2017-08-28       Impact factor: 2.327

Review 3.  GB virus C: the good boy virus?

Authors:  Nirjal Bhattarai; Jack T Stapleton
Journal:  Trends Microbiol       Date:  2012-02-08       Impact factor: 17.079

4.  Nuclear import sequence identification in hOAS3 protein.

Authors:  Lucia Malaguarnera; Giuseppe Nunnari; Michelino Di Rosa
Journal:  Inflamm Res       Date:  2016-07-05       Impact factor: 4.575

5.  IFNL4 and IFNL3 associated polymorphisms strongly influence the spontaneous IFN-alpha receptor-1 expression in HCV-infected patients.

Authors:  Licia Bordi; Claudia Caglioti; Anna Rosa Garbuglia; Daniele Lapa; Concetta Castilletti; Chiara Taibi; Maria Rosaria Capobianchi; Eleonora Lalle
Journal:  PLoS One       Date:  2015-02-12       Impact factor: 3.240

6.  Antagonistic antiviral activity between IFN-lambda and IFN-alpha against lethal Crimean-Congo hemorrhagic fever virus in vitro.

Authors:  Licia Bordi; Eleonora Lalle; Claudia Caglioti; Damiano Travaglini; Daniele Lapa; Patrizia Marsella; Serena Quartu; Zoltan Kis; Kevin K Arien; Hartwig P Huemer; Silvia Meschi; Giuseppe Ippolito; Antonino Di Caro; Maria R Capobianchi; Concetta Castilletti
Journal:  PLoS One       Date:  2015-02-18       Impact factor: 3.240

7.  IFN-Alpha receptor-1 upregulation in PBMC from HCV naïve patients carrying cc genotype. possible role of IFN-lambda.

Authors:  Eleonora Lalle; Licia Bordi; Claudia Caglioti; Anna Rosa Garbuglia; Concetta Castilletti; Chiara Taibi; Francesca Cristofari; Maria Rosaria Capobianchi
Journal:  PLoS One       Date:  2014-04-01       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.